Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gordon Bruton is active.

Publication


Featured researches published by Gordon Bruton.


Chemical Communications | 2002

An efficient synthesis of endo,exo-furofuranone derivatives

Nigel A. Swain; Richard C. D. Brown; Gordon Bruton

The ring openings of 1-acetyl-4-phenyl-3-oxabicyclo[3.1.0]hexane afforded alpha-acetyl-gamma-butyrolactone that underwent a novel diazo-transfer reaction, followed by C-H insertion, to provide a series of endo,exo-furofuranone analogues.


ChemMedChem | 2018

Identifying Small‐Molecule Binding Sites for Epigenetic Proteins at Domain–Domain Interfaces

David Bowkett; R. Talon; Cynthia Tallant; Christopher J. Schofield; Frank von Delft; Stefan Knapp; Gordon Bruton; Paul E. Brennan

Epigenetics is a rapidly growing field in drug discovery. Of particular interest is the role of post‐translational modifications to histones and the proteins that read, write, and erase such modifications. The development of inhibitors for reader domains has focused on single domains. One of the major difficulties of designing inhibitors for reader domains is that, with the notable exception of bromodomains, they tend not to possess a well‐enclosed binding site amenable to small‐molecule inhibition. As many of the proteins in epigenetic regulation have multiple domains, there are opportunities for designing inhibitors that bind at a domain–domain interface which provide a more suitable interaction pocket. Examination of X‐ray structures of multiple domains involved in recognising and modifying post‐translational histone marks using the SiteMap algorithm identified potential binding sites at domain–domain interfaces. For the tandem plant homeodomain–bromodomain of SP100C, a potential inter‐domain site identified computationally was validated experimentally by the discovery of ligands by X‐ray crystallographic fragment screening.


Biochemical Pharmacology | 2007

Structurally novel histamine H3 receptor antagonists GSK207040 and GSK334429 improve scopolamine-induced memory impairment and capsaicin-induced secondary allodynia in rats

Andrew D. Medhurst; Michael A. Briggs; Gordon Bruton; Andrew R. Calver; Iain P. Chessell; Barry Crook; John B. Davis; Robert P. Davis; Andrew G. Foley; Teresa Heslop; Warren D. Hirst; Stephen J. Medhurst; Sandrine Ociepka; Alison M. Ray; Ciaran M. Regan; Becky Sargent; Joanne Schogger; Tania O. Stean; Brenda K. Trail; Neil Upton; Trevor White; Barry Sidney Orlek; David M. Wilson


Journal of Organic Chemistry | 2001

C−H Insertion Approach to the Synthesis of endo,exo-Furofuranones: Synthesis of (±)-Asarinin, (±)-Epimagnolin A, and (±)-Fargesin

Richard C. D. Brown; Carole J. R. Bataille; Gordon Bruton; Jeremy David Hinks; Nigel A. Swain


Archive | 2003

Aryloxyalkylamine derivates as h3 receptor ligands

Desmond John Best; Gordon Bruton; Thomas Daniel Heightman; Barry Sidney Orlek


Journal of Organic Chemistry | 2004

A versatile stereoselective synthesis of endo,exo-furofuranones: application to the enantioselective synthesis of furofuran lignans.

Nigel A. Swain; Richard C. D. Brown; Gordon Bruton


European Journal of Medicinal Chemistry | 2003

Lipopeptide substrates for SpsB, the Staphylococcus aureus type I signal peptidase: design, conformation and conversion to α-ketoamide inhibitors

Gordon Bruton; Anthony Huxley; Peter J. O'Hanlon; Barry Sidney Orlek; Drake Eggleston; John Humphries; Simon A. Readshaw; Andrew West; Stephen Ashman; Murray J.B. Brown; Keith Moore; Andrew J. Pope; Karen O'Dwyer; Lei Wang


Archive | 2000

(hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives

Gordon Bruton; Andrew SmithKline Beecham Pharmac. Faller; Barry Sidney mithKline Beecham Pharmac. Orlek; Kishore Kalidas Rana; Graham Walker


Archive | 2008

USE OF QUINOLINE DERIVATIVES IN THE TREATMENT OF PAIN AND IRRITABLE BOWEL SYNDROME

Gordon Bruton; Barry Sidney Orlek; Geoffrey Stemp


Archive | 2004

Piperazine derivates and their use for the treatment of neurological and psychiatric diseases

Gordon Bruton; Barry Sidney Orlek; Kishore Kalidas Rana

Collaboration


Dive into the Gordon Bruton's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nigel A. Swain

University of Southampton

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge